Drug Shortage Report for TEVA-CANDESARTAN/HCTZ
| Report ID | 237989 |
| Drug Identification Number | 02395541 |
| Brand name | TEVA-CANDESARTAN/HCTZ |
| Common or Proper name | CANDESARTAN/HCTZ 16/12.5MG TB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL |
| Strength(s) | 12.5MG 16MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | PP |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-09-18 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-08-08 |
| Company comments | item is on suspended Supply |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v28 | 2025-08-08 | French | Compare |
| v27 | 2025-08-08 | English | Compare |
| v26 | 2025-07-10 | French | Compare |
| v25 | 2025-07-10 | English | Compare |
| v24 | 2025-06-27 | French | Compare |
| v23 | 2025-06-27 | English | Compare |
| v22 | 2025-06-13 | French | Compare |
| v21 | 2025-06-13 | English | Compare |
| v20 | 2025-05-15 | French | Compare |
| v19 | 2025-05-15 | English | Compare |
| v18 | 2025-05-02 | French | Compare |
| v17 | 2025-05-02 | English | Compare |
| v16 | 2025-04-24 | French | Compare |
| v15 | 2025-04-24 | English | Compare |
| v14 | 2025-04-24 | French | Compare |
| v13 | 2025-04-24 | English | Compare |
| v12 | 2025-03-27 | French | Compare |
| v11 | 2025-03-27 | English | Compare |
| v10 | 2025-01-30 | French | Compare |
| v9 | 2025-01-30 | English | Compare |